Otwarty dostęp

Evaluation of dosimetric effect caused by slowing with multi-leaf collimator (MLC) leaves for volumetric modulated arc therapy (VMAT)

Zhengzheng Xu

Zhengzheng Xu

  • Department of Radiation Medicine, Roswell Park Cancer Institute, BuffaloNY, United States
  • Department of Physiology and Biophysics, State University of New York at BuffaloNY, United States
Wyszukaj tego autora
Sciendo|Google Scholar
Xu, Zhengzheng
, 
Iris Z. Wang

Iris Z. Wang

  • Department of Radiation Medicine, Roswell Park Cancer Institute, BuffaloNY, United States
  • Department of Physiology and Biophysics, State University of New York at BuffaloNY, United States
Wyszukaj tego autora
Sciendo|Google Scholar
Wang, Iris Z.
, 
Lalith K. Kumaraswamy

Lalith K. Kumaraswamy

Department of Radiation Medicine, Roswell Park Cancer Institute, BuffaloNY, United States
Wyszukaj tego autora
Sciendo|Google Scholar
Kumaraswamy, Lalith K.
 oraz 
Matthew B. Podgorsak

Matthew B. Podgorsak

  • Department of Radiation Medicine, Roswell Park Cancer Institute, BuffaloNY, United States
  • Department of Physiology and Biophysics, State University of New York at BuffaloNY, United States
Wyszukaj tego autora
Sciendo|Google Scholar
Podgorsak, Matthew B.
  
16 lut 2016
Evaluation of dosimetric effect caused by slowing with multi-leaf collimator (MLC) leaves for volumetric modulated arc therapy (VMAT)'s Cover Image
O artykule
Poprzedni artykuł
Następny artykuł
Zacytuj
Pobierz okładkę
Kategoria artykułu: Research Article
Data publikacji: 16 lut 2016
Zakres stron: 121 - 128
Otrzymano: 16 cze 2015
Przyjęty: 19 paź 2015
DOI: https://doi.org/10.1515/raon-2016-0008
Słowa kluczowe
© 2016 Radiol Oncol
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Figure 1.

Illustration of multi-leaf collimator (MLC) leaf position modifications of one leaf when it is moving with the highest speed at two consecutive control points (CPs) (i.e. CP2 and CP3). (A) The leaf is moving in the same direction. (B) The leaf is moving back and forth. Red arrow (Vmaxl or 2.3cm/s) represents leaf speed from CP1 to CP2; Black arrow (Vmax2 or 2.3cm/s) represents leaf speed from CP2 to CP3. Black bars represent original leaf positions. Blue bars represent new leaf positions after modification.
Illustration of multi-leaf collimator (MLC) leaf position modifications of one leaf when it is moving with the highest speed at two consecutive control points (CPs) (i.e. CP2 and CP3). (A) The leaf is moving in the same direction. (B) The leaf is moving back and forth. Red arrow (Vmaxl or 2.3cm/s) represents leaf speed from CP1 to CP2; Black arrow (Vmax2 or 2.3cm/s) represents leaf speed from CP2 to CP3. Black bars represent original leaf positions. Blue bars represent new leaf positions after modification.

Figure 2.

Variation of pass rates (3%/3mm) of each volumetric modulated arc therapy (VMAT) arc. Solid dots: pass rates of arcs in ‘standard’ plans (PSstandard). Soft dots: pass rates of arcs in ‘slowing multi-leaf collimator (MLC)’ plans (PSslowing MLC). Error bars are pass rates variation based on repeated measurements of each arc on two consecutive days.
Variation of pass rates (3%/3mm) of each volumetric modulated arc therapy (VMAT) arc. Solid dots: pass rates of arcs in ‘standard’ plans (PSstandard). Soft dots: pass rates of arcs in ‘slowing multi-leaf collimator (MLC)’ plans (PSslowing MLC). Error bars are pass rates variation based on repeated measurements of each arc on two consecutive days.

Figure 3.

Pass rates of ‘standard’ volumetric modulated arc therapy (VMAT) plans with respect to absolute dose Van Dyk distance-to-agreement (DTA) comparisons using 3%/ 3 mm and 2%/2 mm criteria.
Pass rates of ‘standard’ volumetric modulated arc therapy (VMAT) plans with respect to absolute dose Van Dyk distance-to-agreement (DTA) comparisons using 3%/ 3 mm and 2%/2 mm criteria.

Figure 4.

Pass rates of ‘slowing multi-leaf collimator (MLC)’ volumetric modulated arc therapy (VMAT) plans with respect to absolute dose Van Dyk distance-to-agreement (DTA) comparisons using 3%/ 3 mm and 2%/2 mm criteria.
Pass rates of ‘slowing multi-leaf collimator (MLC)’ volumetric modulated arc therapy (VMAT) plans with respect to absolute dose Van Dyk distance-to-agreement (DTA) comparisons using 3%/ 3 mm and 2%/2 mm criteria.

Figure 5 (A)

DVH comparison between ‘standard’ and ‘slowing MLC’ VMAT plans of anal case A3. (B) DVH comparison between ‘standard’ and ‘slowing MLC’ VMAT plans of anal case A4. ▲:’slowing MLC’ plan; ■ :’standard’ plan. Red: PTV; Blue: Rectum; Green: Bladder; Grey: Large bowel; Purple: Small bowel; Orange: Femoral heads
DVH comparison between ‘standard’ and ‘slowing MLC’ VMAT plans of anal case A3. (B) DVH comparison between ‘standard’ and ‘slowing MLC’ VMAT plans of anal case A4. ▲:’slowing MLC’ plan; ■ :’standard’ plan. Red: PTV; Blue: Rectum; Green: Bladder; Grey: Large bowel; Purple: Small bowel; Orange: Femoral heads

Figure 6

Correlation between absolute pass rate difference (|PSstandard (%) – PSslowng MLC (%)|) of each arc and LTMCS of each arc. (A) LTMCS vs decrease in pass rate (%) using 2%/2mm criteria; (B) LTMCS vs decrease in pass rate (%) using 3%/3mm criteria
Correlation between absolute pass rate difference (|PSstandard (%) – PSslowng MLC (%)|) of each arc and LTMCS of each arc. (A) LTMCS vs decrease in pass rate (%) using 2%/2mm criteria; (B) LTMCS vs decrease in pass rate (%) using 3%/3mm criteria

Figure 7

MapCHECK®2 measurements of single arc of case A4. (A) Red dots are MapCHECK®2 measurements of ‘slowing MLC’ plan showing delivered dose is higher than planed dose (‘standard’ plan); (B) Dotted line represents dose profile of ‘slowing MLC’ plan; Black solid line represents dose profile of ‘standard’ plan.
MapCHECK®2 measurements of single arc of case A4. (A) Red dots are MapCHECK®2 measurements of ‘slowing MLC’ plan showing delivered dose is higher than planed dose (‘standard’ plan); (B) Dotted line represents dose profile of ‘slowing MLC’ plan; Black solid line represents dose profile of ‘standard’ plan.

Demonstration of the impact on leaf speed of adjacent control points (CPs) due to leaf modifications

Scenario

Scenario A: Leaf moved forward from LP1 to LP2, then moved forward from LP2 to LP3.

LP1 (cm)LP2 (cm)LP3 (cm)LP1-2 Speed (cm/s)LP 2-3 Speed (cm/s)
A (ori)4.65.45.91.81.1
A (mod)4.65.65.92.30.7
B (ori)4.65.44.91.8−1.1
B (mod)4.65.64.92.3−1.6

Target dose differences between ‘standard’ and ‘slowing multi-leaf collimator (MLC)’ anal volumetric modulated arc therapy (VMAT) plans, total leave states, and average percentages of modified leaves and faster moving leaves of anal cases

Case∆Dmean(Gy)

Negative sign means dose of ‘standard’ plan is lower than that of ‘slowing MLC’ plan CP = control point

∆D95(Gy)

Negative sign means dose of ‘standard’ plan is lower than that of ‘slowing MLC’ plan CP = control point

Total leave states per arc (leaves on both banks/CP)×(CP)Average modified MLC leaves (%)Average faster moving leaves (%)
A1−0.8−0.2120 × 1781.756.5
A2−0.9−0.3120 × 1781.653.6
A3−1.2−0.5120 × 1781.751.3
A4−2.2−1.0120 × 1782.369.0
A5−1.1−0.3120 × 1781.752.7

Volumetric modulated arc therapy (VMAT) plan parameters (dose, gantry speed, Leaf travel and modulation complexity score [LTMCS] and arcs), ranges of the maximal leaf speed, multi-leaf collimator (MLC) leaf position changes along 178 control points (CPs), and total modified leaves percentage of each VMAT arc

Case

P: Prostate VMAT cases; B: Brain VMAT cases; A: Anal VMAT cases.

Dose Prescription (Gy/fx × fx)Gantry speed (deg/s)LTMCS

Leaf travel and modulation complexity score (LTMCS) for a VMAT plan. LTMCS ranges from 0 to 1. Low LTMCS indicates high modulation complexity.

ArcMaximal MLC leaf speed range along 178 CPs (cm/s)Range of Leaf Position Changes along 178 CPs (mm)Total Modified MLC leaves %
P12.0 × 334.80.16411.87-1.92−1.90-1.881.5
P22.0 × 334.80.26211.87-1.90−1.90-2.001.6
21.87-1.90−1.90-2.001.6
P32.0 × 334.80.16311.87-1.90−1.90-2.001.5
21.87-1.90−1.90-2.001.6
B11.8 × 334.80.20411.87-1.92−1.88-1.901.6
B21.8 × 334.80.19911.87-1.92−1.88-1.901.5
21.87-1.92−1.88-1.901.7
B31.8 × 334.80.21711.85-1.90−1.88-2.001.5
21.85-1.90−1.88-2.001.6
A11.8 × 334.80.08111.90-1.92−1.80-1.801.7
21.90-1.92−1.80-1.801.7
31.90-1.92−1.80-1.801.7
41.90-1.92−1.80-1.801.8
A21.8 × 334.80.08311.92-1.95−1.87-1.871.5
21.92-1.95−1.87-1.871.6
31.92-1.95−1.87-1.871.6
41.92-1.95−1.87-1.871.5
A31.8 × 334.80.10511.92-1.95−1.87-1.871.7
21.92-1.95−1.87-1.871.7
31.92-1.95−1.87-1.871.7
A41.8 × 334.80.07611.87-1.90−1.80-1.932.2
21.87-1.90−1.80-1.932.2
31.87-1.90−1.80-1.932.3
41.87-1.90−1.80-1.932.3
A51.8 × 334.80.08411.90-1.92−1.80-1.801.7
21.90-1.92−1.80-1.801.7
31.90-1.92−1.80-1.801.8
Język:
Angielski
Częstotliwość wydawania:
4 razy w roku
Dziedziny czasopisma:
Medycyna, Medycyna kliniczna, Medycyna wewnętrzna, Hematologia, onkologia, Radiologia
Kanał RSS czasopisma